Cetera Advisors’s Calumet Specialty Products CLMT Stock Holding History

Cetera Advisors’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-11,906	Closed	-$304K	–	688
2015 Q2	$304K	Buy	+11,906	New	+$316K	0.03%	518
2014 Q3	–	Sell	-6,499	Closed	-$205K	–	623
2014 Q2	$205K	Buy	+6,499	New	+$193K	0.02%	537

Other funds holding CLMT

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

SOAMC

Spirit of America Management Corp Syosset, New York $530M AUM 36.47% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RIM

Rainier Investment Management Seattle, Washington $237M AUM 27.07% 1-Year Est. Return

SCA

Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return

Cetera Advisors's CLMT Position: Q3 2015 in Review

Cetera Advisors sold out of Calumet Specialty Products (CLMT) in Q3 2015, closing a stake of 11,906 shares — an estimated $304K sold.

Cetera Advisors first reported a position in CLMT in Q2 2014 and held it in 2 quarters. The position peaked at $304K in Q2 2015. 117 funds tracked by Wall St. Rank hold CLMT as of Q3 2015.

Cetera Advisors reported no remaining Calumet Specialty Products position as of Q3 2015 after selling out during the quarter.
Cetera Advisors sold 11,906 Calumet Specialty Products shares in Q3 2015, an estimated $304K.
Cetera Advisors first reported a position in Calumet Specialty Products in Q2 2014 and held it in 2 quarters.
Cetera Advisors's Calumet Specialty Products position peaked at $304K in Q2 2015.
117 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2015.

Based on Cetera Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.